Browsing by Author Kao, Steven

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 35  next >
Issue DateTitleAuthor(s)Citation
2012Aquaporin 1 is an independent prognostic factor in pleural malignant mesotheliomaKao, Steven; McCaughan, Brian; Armstrong, Nicola; Condon, Bridget; Griggs, Kim; Henderson, Douglas W; Klebe, Sonja; Maltby, Sarah; Wilson, Alan; Concord Clinical School: Medicine; Central Clinical School: SurgeryAquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma, Cancer, vol.118, 11, 2012,pp 2952-2961
2015BRAF mutations in non-small cell lung cancerCooper, Wendy Anne; O'Toole, Sandra; Yu, Bing; Kao, Steven; Luk, Peter; Lum, Trina; Mercorella, B; Ng, Chiu Chin; Selinger, Christina; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: MedicineBRAF mutations in non-small cell lung cancer, Translational Lung Cancer Research, vol.4, 2, 2015,pp 142-148
2016Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional studyKao, Steven; Reid, Glen; van Zandwijk, Nico; Dong, Yawen; et al, .; Ghanim, Bahil; Hoda, Mir Alireza; Jakopovic, Marko; Klikovits, Thomas; Laszlo, Viktoria; Ozsvar, Judit; Rozsas, Anita; Stockhammer, Paul; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteCirculating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study, European Journal of Cancer, vol.63, N/A, 2016,pp 64-73
2016Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancerBoyer, Michael; Clarke, Stephen; Kao, Steven; Pavlakis, Nick; Reid, Glen; van Zandwijk, Nico; Brahmbhatt, Himanshu; MacDiarmid, Jennifer; Central Clinical School: Medicine; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Northern Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteClinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer, Epigenomics, vol.8, 8, 2016,pp 1079-1085
2018Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trialsBeith, Jane; Boyer, Michael; Kao, Steven; McNeil, Catriona; Prasanna, Thiru; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineDose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials, Asia-Pacific Journal of Clinical Oncology, vol.14, 3, 2018,pp 125-133
2012The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trialsClarey, Jamie; Clarke, Stephen; Kao, Steven; Vardy, Janette; Medicine; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Concord Clinical School: MedicineThe eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials, Annals of Oncology, vol.23, 5, 2012,pp 1229-1233
2015Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer careClarke, Stephen; Kao, Steven; van Zandwijk, Nico; Vardy, Janette; Lumba, Sumit; Ng, Weng; Tognela, Annette; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineEstimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer care, Asia-Pacific Journal of Clinical Oncology, vol.11, N/A, 2015,pp 85-92
2013Excision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With MesotheliomaClarke, Stephen; Kao, Steven; van Zandwijk, Nico; Vardy, Janette; Henderson, Douglas; Klebe, Sonja; Lee, Kenneth; McCaughan, Brian; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineExcision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With Mesothelioma, Clinical Lung Cancer, vol.14, 2, 2013,pp 164-171
2014Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South WalesClarke, Stephen; Kao, Steven; Linton, Anthony; Pavlakis, Nick; Soeberg, Matthew; van Zandwijk, Nico; Vardy, Janette; O’Connell, R; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Northern Clinical School: Medicine; School of Public Health: Public Health; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineFactors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales, British Journal of Cancer, vol.111, 9, 2014,pp 1860-1869
2015Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosisEdelman, John (James); Kao, Steven; Kirschner, Michaela; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Cheng, YuenYee; Dong, Yawen; Emily, Pulford; et al, Various; Griggs, Kim; Grusch, Michael; Hoda, Mir Alireza; Hyland, Rebecca; Klikovits, Thomas; Laszlo, Viktoria; Rozsas, Anita; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteFibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis, British Journal of Cancer, vol.113, 6, 2015,pp 963-969
2017Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomesKao, Steven; Linton, Anthony; van Zandwijk, Nico; Broome, R; Soeberg, Matthew; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: MedicineGeographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes, Respirology, vol.22, 5, 2017,pp 978-985
2011Haemolysis during Sample Preparation Alters microRNA Content of Plasma.Edelman, John; Kao, Steven; Kirschner, Michaela; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Armstrong, Nicola; School of Medical Sciences: Physiology; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteHaemolysis during Sample Preparation Alters microRNA Content of Plasma., PLoS One, vol.6, 9, 2011,pp e24145-N/A
2013Health-related quality of life and inflammatory markers in malignant pleural mesotheliomaClarke, Stephen; Kao, Steven; Pavlakis, Nick; Vardy, Janette; Chatfield, Mark D; Harvie, Rozelle; Van Zandwijk, Nico; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Northern Clinical School: Medicine; Concord Clinical School: MedicineHealth-related quality of life and inflammatory markers in malignant pleural mesothelioma, Supportive Care in Cancer, vol.21, 3, 2013,pp 697-705
2013Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: Trends in Australia and a literature reviewClarke, Stephen; Kao, Steven; Linton, Anthony; van Zandwijk, Nico; Vardy, Janette; Klebe, Sonja; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineImmunohistochemistry in the diagnosis of malignant pleural mesothelioma: Trends in Australia and a literature review, Asia Pacific Journal of Clinical Oncology, vol.9, 3, 2013,pp 273-279
2018Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic ParadigmsBarnet, Megan; Boyer, Michael; Cooper, Wendy Anne; Kao, Steven; Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineImmunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms, Journal of Clinical Medicine, vol.7, 6, 2018,pp 151-N/A
2013The Impact of Hemolysis on Cell-Free microRNA BiomarkersEdelman, John (James); Kao, Steven; Kirschner, Michaela; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteThe Impact of Hemolysis on Cell-Free microRNA Biomarkers, Frontiers in Genetics, vol.4, N/A, 2013,pp 1-13
2012Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural MesotheliomaCheng, Victoria (Yuen); Edelman, John (James); Kao, Steven; Kirschner, Michaela; McCaughan, Brian; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Armstrong, Nicola; Badrian, Bahareh; Creaney, Jenette; Klebe, Sonja; Musk, A. W.; Mutsaers, Steven; Robinson, Bruce W.S.; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteIncreased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma, Journal of Thoracic Oncology, vol.7, 7, 2012,pp 1184-1191
2011Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural PneumonectomyChatfield, Mark; Clarke, Stephen; Kao, Steven; McCaughan, Brian; Reid, Glen; van Zandwijk, Nico; Vardy, Janette; Armstrong, Nicola; Henderson, Douglas W; Klebe, Sonja; Yan, Tristan; Clinical Schools; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineLow Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy, Journal of Thoracic Oncology, vol.6, 11, 2011,pp 1923-1929
2015miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaCooper, Wendy Anne; Edelman, John (James); Hanh, Jacky; Kao, Steven; Kirschner, Michaela; Linton, Anthony; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Amaro-Mugridge, Nancy; Brahmbhatt, Himanshu; Cheng, YuenYee; Klebe, Sonja; Lin, Ruby C. Y.; MacDiarmid, Jennifer; McCaughan, Brian; Weiss, Jocelyn; Williams, Marissa; Wright, Casey; Central Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstitutemiR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma, Oncotarget, vol.6, 27, 2015,pp 23480-23495
2015MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesotheliomaArmstrong, Nicola Joy; Cheng, Yuen Yee; Kao, Steven; Kirschner, Michaela; Lin, Ruby; Linton, Anthony; McCaughan, Brian; Reid, Glen; van Zandwijk, Nico; Klebe, Sonja; Mathematics & Statistics; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Molecular Bioscience; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteMiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma, Molecular Oncology, vol.9, N/A, 2015,pp 715-726